AC-186

N/A

Report date: 2023/05/17 18:07:21
NME

Base Information

Drug NameAC-186
Drug Alias NameAC-186
ClassificationSmall molecules
Mechanisms of ActionEstrogen receptor beta agonists
TargetsEstrogen receptor beta
Therapy Area/IndicationsMultiple Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAcadia Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAcadia Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsMultiple Sclerosis

Other Information

ATC CodeN/A
Related LinksN/A